Lopinavir/Ritonavir: A Review of its Use in the Management of HIV-1 Infection
Lopinavir/Ritonavir: A Review of its Use in the Management of HIV-1 Infection
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Lopinavir/ritonavir (Kaletra®) is an orally administered coformulated ritonavir-boosted protease inhibitor (PI) comprising lopinavir and low-dose ritonavir. It is indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults, adolescents and children. Lopinavir/ritonavir is available as a tablet, soft-ge...
Alternative Titles
Full title
Lopinavir/Ritonavir: A Review of its Use in the Management of HIV-1 Infection
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_893268244
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_893268244
Other Identifiers
ISSN
0012-6667
E-ISSN
1179-1950
DOI
10.2165/11204950-000000000-00000
